Big Secrets Benefit Big Industry

Trade secrets: the fuzzy line between freedom of information and intellectual property rights In late November 2013, the European Commission released its proposed directive on the “protection of undisclosed know-how and business information (trade secrets) against their unlawful acquisition, use and disclosure” with the objective of reinforcing the protection of so-called trade secrets. This proposal … Read More.

Innovation hearing re-invents the wheel

A new article in The Huffington Post starts with the question, “Whatever happened to innovation in America?” and concludes by hinting that American innovation is not what it once was. According to studies cited by the authors, the United States is second to last in terms of progress over the past decade. So, who are … Read More.

Known Unknowns

In reflecting on his revolutionary achievements, Sir Isaac Newton explained, “If I have seen further it is by standing on the shoulders of giants.”  Implicit in this statement is the recognition of information as an essential part of the foundation for technological innovation. In the 21st century, information has captured the attention of a broad … Read More.

US Dept. of Justice says no patents on genes

In a recently filed amicus brief, the US Department of Justice (DOJ) departed from long standing US case law and policy that allows for the patenting of isolated genes, arguing that isolated genes are part of nature and thus not patent eligible.  Both biotechnology and medical industry trade associations argue that these patents continue to … Read More.

UPOV increases transparency

UPOV is entering a new era of transparency & inclusiveness. The decision of the International Union for the Protection of New Varieties of Plants (UPOV) to grant observer status to civil society and farmers’ organizations at its annual ordinary session on October 21, 2010 suggest the possibility of a new era of transparency and inclusiveness … Read More.

New Treaty on Biotechnology Adopted

Nagoya, 16 October 2010 At 6.15 p.m. Friday here in Japan, a new international treaty, “the Nagoya – Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety”, was adopted at one of the largest intergovernmental meetings ever held on the safe use of modern biotechnology. The adoption of the new … Read More.

Colombian IP Agreement continues to Raise Human Rights Concerns

During Colombia’s periodic review by the Office of the UN High Commissioner for Human Rights, specifically the Committee on Economic, Social and Cultural Rights, several recommendations were made relating to intellectual property (IP) rights. The official UN report can be found here and CIEL’s publications relating to Trade Agreements and IP can be accessed here. … Read More.

Balancing or Swinging? Genes, ACTA and other Recent Developments in IP

The past thirty days have given those who follow developments in innovation policy quite a bit of material. First, on March 29th, a US district court (SDNY) held that neither isolated genes nor methods of analyzing or comparing genes were patentable subject matter in Association for Molecular Pathology v. US Patent and Trademark Office (USPTO). … Read More.

Technology Mechanism for Climate Change: Still in the Lab

The first set of 2010 climate change negotiations under the UNFCCC concluded in Bonn, Germany (April 9-11th) with no progress apparent on the Technology Mechanism referenced in Paragraph 11 of the 2009 Copenhagen Accord. In fact, the only real outcome of the meeting appears to be an agreement to hold two additional meetings for both … Read More.

World Bank discusses Trade and Climate Change

The World Bank, along with two other NGOs, held a panel discussion today on the trade implications of the ongoing climate negotiations. The final presentation, on Technology Transfer and Climate Change was the most substantive, as detailed below. The presentations did not address either labeling schemes, standards, border carbon adjustments, or subsidies. For an in … Read More.